NCT00144313View on ClinicalTrials.gov

VaxTeen Hepatitis B Vaccine Booster Study

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

January 31, 2006

Conditions
Hepatitis
Interventions
BIOLOGICAL

hepatitis B vaccine

Trial Locations (1)

99508

CDC Arctic Investigations Program, Anchorage

All Listed Sponsors
collaborator

Alaska Native Medical Center

OTHER

lead

Centers for Disease Control and Prevention

FED

NCT00144313 - VaxTeen Hepatitis B Vaccine Booster Study | Biotech Hunter | Biotech Hunter